Concepedia

The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma

Korbinian N. Kropp, Stefanie Maurer, Kathrin Rothfelder, Bastian J. Schmied, Kim L. Clar, Moritz Schmidt, Benedikt Strunz, Hans‐Georg Kopp, Alexander Steinle, Frank Grünebach,

Cancer Immunology Immunotherapy · 2018 · 24 citations · 38 references

DOIFull text

Open access

Concepts

References

38

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Richard I. Fisher, Steven H. Bernstein, Brad S. Kahl et al. · Journal of Clinical Oncology · 2006 · 708 citations

, , +15

Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of  TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells

Loris Zamai, Manzoor Ahmad, Ian M. Bennett et al. · The Journal of Experimental Medicine · 1998 · 546 citations · Full text

, , +17

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

Helmut R. Salih, Holger Antropius, Friederike Gieseke et al. · Blood · 2003 · 532 citations

, , +14

Inhibition of proteasome deubiquitinating activity as a new cancer therapy

Pádraig D’Arcy, Slavica Brnjic, Maria Hägg Olofsson et al. · Nature Medicine · 2011 · 497 citations · Full text

, , +14

ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

Alessandra Soriani, Alessandra Zingoni, Cristina Cerboni et al. · Blood · 2008 · 435 citations · Full text

, , +16